Founded in 2023, Oncare operates in Health Tech industry. Initially focused on providing technology-driven cancer treatment solutions, the company has evolved to include a patient-centric ecosystem th...
Funding stage:
Series A
Last funding:
23/02/2026
Total funding:
$4.00 Mn+
Revenue:
Investors
Employee count:
88
Last 90d
88
Last 90d
Web traffic:
53.84K
53.84K
Last 30d
Last 30d
Oncare: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders21
Latest Filing Date03 Feb 2026- Funding Events6
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Oncare
As of 04 February 2026, Oncare's equity is held by 20 shareholders, with the top three being Amar Sneh, Deepak Kumar, and Huddle Venture Fund.
Amar Sneh holds the largest stake in Oncare at 25.4% as of 04 February 2026.
As of 04 February 2026, founders collectively hold 50.7% equity in Oncare.
As of 04 February 2026, investors collectively hold 32.4% equity in Oncare.
Oncare's ESOP pool stands at 16.9% of total equity as of 04 February 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links